Similarly, the anti-inflammatory effect of Fusicatenibacter, particularly its F. saccharivorans species, has recently been demonstrated in patients and mouse models with ulcerative colitis (40) and Crohn’s disease through IL-10 induction (41, 42). Here, IL10 is linked to Crohn disease.